SCHEMBL23609573

SCHEMBL23609573

CNCC1(CN(C)C)COC1

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PRMT3 O60678 1/20 0.32
CARM1 Q86X55 1/20 0.32
PRMT6 Q96LA8 1/20 0.32
PRMT1 Q99873 1/20 0.32
PRMT8 Q9NR22 1/20 0.32
EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23609252 0.83 EPHX1 (0.30) EPHX1
SCHEMBL10113850 0.81 EPHX1 (0.38) EPHX1
SCHEMBL23609402 0.78 FGFR1 (0.33)
SCHEMBL23609025 0.75 EPHX1 (0.33) EPHX1
SCHEMBL13709029 0.75
SCHEMBL23275868 0.73 EPHX1 (0.48) EPHX1
SCHEMBL8912503 0.73
SCHEMBL13946890 0.73
SCHEMBL25798243 0.71
SCHEMBL23608903 0.70 EPHX1 (0.30) EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195346-A1 LIPOXYGENASE INHIBITORS SRI INTERNATIONAL (US) 2021-09-30 WO disclosed
WO-2021133689-A2 LIPOXYGENASE INHIBITORS SRI INTERNATIONAL (US) 2021-07-01 WO disclosed